Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Health

Webinar on Bacteriophages and AMR One Health Perspective

On April 18, 2024, from 13:00 to 14:30 CEST, an online webinar titled ‘Towards building the evidence for broader use of bacteriophages from an AMR One Health perspective’ will be held. Bacteriophages, which are viruses that selectively target and kill bacteria, are gaining attention for their potential in combating antimicrobial resistance (AMR). This phenomenon poses a significant global health threat, leading to increased morbidity, mortality, and healthcare costs.

The fight against AMR calls for a multifaceted approach that encompasses human, animal, and environmental health, known as the One Health approach. Bacteriophages present a promising alternative or adjunct to traditional antibiotics. However, their broader adoption necessitates robust evidence to support their efficacy, safety, and feasibility across One Health sectors.

The WHO European Region’s eastern part has a rich history of utilizing phage therapy, with the George Eliava Institute of Bacteriophages, Microbiology, and Virology in Georgia being the world’s oldest center for bacteriophage research and application.

In collaboration with the Global Antimicrobial Resistance Research and Development Hub, WHO/Europe is hosting a series of three webinars to expedite evidence development for the application of bacteriophages within the One Health framework.

The first webinar will concentrate on the opportunities and challenges associated with the application of bacteriophages for human health. It aims to explore the current state of knowledge and evidence gaps, discuss the challenges and opportunities linked to the broader implementation of phage therapy in human health settings, and identify strategies for building the evidence base to support their use in combating AMR.

The webinar will feature distinguished speakers including Dr. Radu Botgros from the European Medicines Agency, Dr. Mariam Dadiani from the George Eliava Institute in Georgia, Dr. Mercedes González Moreno from INCATE, Dr. Frédéric Laurent from Croix-Rousse Hospital in France (moderator), Dr. Shawna McCallin from Balgrist University Hospital in Switzerland, and Dr. Jean-Paul Pirnay from Queen Astrid Military Hospital in Belgium.

Those interested can register for the webinar via the provided link to gain insights into this crucial topic.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *